Two major President Trump-centric events have been unfolding these past few weeks, and each has alternatingly claimed the limelight and been overshadowed by the other. First, we have the ongoing Senate impeachment hearings, which began January 16, and second, phase one of the U.S.-China trade deal, which was signed and made public on January 15.
Not long ago Hemp Industry Daily reported on a decision by U.S. District Judge Ursula Ungaro in the Southern District of Florida in which the Court stayed a putative class action lawsuit against a seller of CBD products until the FDA completes rulemaking regarding the marketing, including labelling, of hemp-derived ingestible products. The case is
La Ley de Mejora de la Agricultura de 2018 (Farm Bill de 2018) legalizó el cáñamo al excluir este cultivo y sus derivados de la definición de marihuana recogida en la Ley de Sustancias Controladas (CSA) y al establecer un marco normativo detallado para su cultivo. La Farm Bill de 2018 otorga al Departamento de Agricultura de los Estados Unidos (USDA) la competencia reguladora sobre el cáñamo
La Ley de Mejora de la Agricultura de 2018 (Farm Bill de 2018) legalizó el cáñamo al excluir este cultivo y sus derivados de la definición de marihuana recogida en la Ley de Sustancias Controladas (CSA) y al establecer un marco normativo detallado para su cultivo. La Farm Bill de 2018 otorga al Departamento de Agricultura de los Estados Unidos (USDA) la competencia reguladora sobre el cáñamo
We recently received a request from a client to advise them on Shopify’s guidance on selling CBD products on its platform. Specifically, the first paragraph of the guidance states that “[y]ou should consult with an attorney to determine how and where you’re able to sell your product.” And that’s exactly what the client did –
On January 2, the Food and Drug Administration (“FDA”) issued non-binding guidance (“Guidance”) in which the agency explains how it intends to prioritize enforcement actions to tackle the growing increase in youth use of electronic nicotine delivery systems (“ENDS”)–more commonly and broadly referred to as “e-cigarettes”–as well as to address vaping-associated lung injuries. According to a
The Agricultural Improvement Act of 2018 (2018 Farm Bill) legalized hemp by removing the crop and its derivatives from the definition of marijuana under the Controlled Substances Act (CSA) and by providing a detailed framework for the cultivation of hemp. The 2018 Farm Bill gives the US Department of Agriculture (USDA) regulatory authority over hemp
Esta es la segunda parte de una serie de dos artículos sobre los cannabinoides de moda. Para leer la entrada anterior sobre el cannabigerol (CBG), haz clic aquí. Esta entrada trata sobre el CBN (cannabinol). Al igual que el CBD y el THC, el CBN es una de las más de 100 moléculas que componen la planta de cannabis. El CBN se forma a partir de la oxidación y la descomposición del THC, lo que significa que cuando el THC se calienta y se expone
A year ago, we discussed a shift in nomenclature for hemp-derived cannabidiol (“Hemp-CBD”) products. Many CBD companies have swapped the word “CBD” for the terms “hemp extract” and “full spectrum hemp” in hope of mitigating the risk of FDA and local enforcement actions. As we previously explained, the main impetus behind this movement seems to
La Ley de Mejora de la Agricultura de 2018 (Farm Bill de 2018) legalizó el cáñamo al excluir este cultivo y sus derivados de la definición de marihuana recogida en la Ley de Sustancias Controladas (CSA) y al establecer un marco normativo detallado para su cultivo. La Farm Bill de 2018 otorga al Departamento de Agricultura de los Estados Unidos (USDA) la competencia reguladora sobre el cáñamo
